{"id":"NCT03373201","sponsor":"Vanda Pharmaceuticals","briefTitle":"Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia","officialTitle":"Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-16","primaryCompletion":"2018-03-05","completion":"2018-03-05","firstPosted":"2017-12-14","resultsPosted":"2023-09-15","lastUpdate":"2023-09-15"},"enrollment":320,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Jet Lag Type Insomnia"],"interventions":[{"type":"DRUG","name":"Tasimelteon","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tasimelteon","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.","primaryOutcome":{"measure":"Total Sleep Time in the First Two Thirds of the Night","timeFrame":"1 Day","effectByArm":[{"arm":"Placebo","deltaMin":156.1,"sd":80.67},{"arm":"Tasimelteon","deltaMin":216.4,"sd":69.69}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":["32754110"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":160},"commonTop":["Headache"]}}